{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T14:05:12Z","timestamp":1773756312837,"version":"3.50.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-17-1-0098"],"award-info":[{"award-number":["W81XWH-17-1-0098"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-17-1-0514"],"award-info":[{"award-number":["W81XWH-17-1-0514"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017325","name":"Engineering Research Centers","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000884","name":"Cancer Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005190","name":"Melanoma Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["P30 CA043703"],"award-info":[{"award-number":["P30 CA043703"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008533","name":"Case Comprehensive Cancer Center, Case Western Reserve University","doi-asserted-by":"publisher","award":["UL1TR002548"],"award-info":[{"award-number":["UL1TR002548"]}],"id":[{"id":"10.13039\/100008533","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.jid.2020.12.015","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T09:01:47Z","timestamp":1610010107000},"page":"1802-1809","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Computational Drug Repositioning Identifies Statins as Modifiers of Prognostic Genetic Expression Signatures and Metastatic Behavior in Melanoma"],"prefix":"10.1016","volume":"141","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7884-0865","authenticated-orcid":false,"given":"Wesley Y.","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7902-2912","authenticated-orcid":false,"given":"Sheena T.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9277-5329","authenticated-orcid":false,"given":"E. Ricky","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3111-5754","authenticated-orcid":false,"given":"John J.","family":"Pink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1986-3602","authenticated-orcid":false,"given":"Kevin","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9140-0648","authenticated-orcid":false,"given":"Sancy","family":"Leachman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7389-9983","authenticated-orcid":false,"given":"Amanda W.","family":"Lund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2191-4085","authenticated-orcid":false,"given":"Rajan","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7010-7730","authenticated-orcid":false,"given":"Jeremy S.","family":"Bordeaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2020.12.015_bib1","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1158\/1055-9965.EPI-08-0010","article-title":"CDKN2A\/p16 genetic test reporting improves early detection intentions and practices in high-risk melanoma families","volume":"17","author":"Aspinwall","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jid.2020.12.015_bib2","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/carcin\/bgz153","article-title":"Neural crest-derived tumor neuroblastoma and melanoma share 1p13.2 as susceptibility locus that shows a long-range interaction with the SLC16A1 gene","volume":"41","author":"Avitabile","year":"2020","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jid.2020.12.015_bib3","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1158\/1078-0432.CCR-05-1544","article-title":"Tumor antigen expression in melanoma varies according to antigen and stage","volume":"12","author":"Barrow","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2020.12.015_bib4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10654-009-9396-x","article-title":"Can statin therapy reduce the risk of melanoma? A meta-analysis of randomized controlled trials","volume":"25","author":"Bonovas","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jid.2020.12.015_bib5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/ijc.2910630313","article-title":"Expression of MAGE genes in primary and metastatic cutaneous melanoma","volume":"63","author":"Brasseur","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jid.2020.12.015_bib6","doi-asserted-by":"crossref","first-page":"15894","DOI":"10.1073\/pnas.1208324109","article-title":"Collaborative interplay between FGF-2 and VEGF-C promotes lymphangiogenesis and metastasis","volume":"109","author":"Cao","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2020.12.015_bib7","doi-asserted-by":"crossref","first-page":"e57191","DOI":"10.7554\/eLife.57191","article-title":"Predicting the effect of statins on cancer risk using genetic variants: a Mendelian randomization study in UK Biobank","volume":"9","author":"Carter","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.jid.2020.12.015_bib8","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/jamadermatol.2020.1730","article-title":"Consensus, controversy, and conversations about gene expression profiling in melanoma","volume":"156","author":"Chan","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2020.12.015_bib9","doi-asserted-by":"crossref","first-page":"16022","DOI":"10.1038\/ncomms16022","article-title":"Reversal of cancer gene expression correlates with drug efficacy and reveals therapeutic targets","volume":"8","author":"Chen","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2020.12.015_bib10","first-page":"1339","article-title":"Increased Cul1 expression promotes melanoma cell proliferation through regulating p27 expression","volume":"37","author":"Chen","year":"2010","journal-title":"Int J Oncol"},{"key":"10.1016\/j.jid.2020.12.015_bib11","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/cup.12475","article-title":"Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanoma","volume":"42","author":"Clarke","year":"2015","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.jid.2020.12.015_bib12","first-page":"941","article-title":"Atorvastatin prevents RhoC isoprenylation, invasion, and metastasis in human melanoma cells","volume":"2","author":"Collisson","year":"2003","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jid.2020.12.015_bib13","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1002\/cam4.2474","article-title":"Are 90% of deaths from cancer caused by metastases?","volume":"8","author":"Dillek\u00e5s","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.jid.2020.12.015_bib14","first-page":"3614","article-title":"Levels of cyclin D1 and D3 in malignant melanoma: deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma","volume":"6","author":"Fl\u00f8renes","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2020.12.015_bib15","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1093\/jnci\/djj412","article-title":"Statins, fibrates, and melanoma risk: a systematic review and meta-analysis","volume":"98","author":"Freeman","year":"2006","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jid.2020.12.015_bib16","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jaad.2015.01.009","article-title":"Gene expression profiling for molecular staging of cutaneous melanoma in patients undergoing sentinel lymph node biopsy","volume":"72","author":"Gerami","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2020.12.015_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1158\/1078-0432.CCR-13-3316","article-title":"Development of a prognostic genetic signature to predict the metastatic risk associated with cutaneous melanoma","volume":"21","author":"Gerami","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2020.12.015_bib18","doi-asserted-by":"crossref","first-page":"9818","DOI":"10.1158\/0008-5472.CAN-06-0494","article-title":"High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL","volume":"66","author":"Goldstein","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2020.12.015_bib19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/jmg.2006.043802","article-title":"Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents","volume":"44","author":"Goldstein","year":"2007","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.jid.2020.12.015_bib20","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jaad.2020.03.053","article-title":"Molecular risk prediction in cutaneous melanoma: a meta-analysis of the 31-gene expression profile prognostic test in 1,479 patients","volume":"83","author":"Greenhaw","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2020.12.015_bib21","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1097\/DSS.0000000000001588","article-title":"Estimation of prognosis in invasive cutaneous melanoma: an independent study of the accuracy of a gene expression profile test","volume":"44","author":"Greenhaw","year":"2018","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jid.2020.12.015_bib22","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1001\/jamadermatol.2020.1729","article-title":"Prognostic gene expression profiling in cutaneous melanoma: identifying the knowledge gaps and assessing the clinical benefit","volume":"156","author":"Grossman","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2020.12.015_bib23","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3390\/biom3030408","article-title":"Emerging role of sphingosine-1-phosphate in inflammation, cancer, and lymphangiogenesis","volume":"3","author":"Huang","year":"2013","journal-title":"Biomolecules"},{"key":"10.1016\/j.jid.2020.12.015_bib24","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1038\/onc.2012.239","article-title":"Sox4-mediated Dicer expression is critical for suppression of melanoma cell invasion","volume":"32","author":"Jafarnejad","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.jid.2020.12.015_bib25","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1002\/cncr.27497","article-title":"Prospective analysis of association between use of statins and melanoma risk in the Women\u2019s Health Initiative","volume":"118","author":"Jagtap","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.jid.2020.12.015_bib26","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/jnci\/djs373","article-title":"Dual suppression of the cyclin-dependent kinase inhibitors CDKN2C and CDKN1A in human melanoma","volume":"104","author":"Jalili","year":"2012","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jid.2020.12.015_bib27","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1242\/dev.095026","article-title":"TGF\u03b2 signaling is required for sprouting lymphangiogenesis during lymphatic network development in the skin","volume":"140","author":"James","year":"2013","journal-title":"Development"},{"key":"10.1016\/j.jid.2020.12.015_bib28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejca.2018.09.026","article-title":"Update of survival and cost of metastatic melanoma with new drugs: estimations from the MelBase cohort","volume":"105","author":"Kandel","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jid.2020.12.015_bib29","doi-asserted-by":"crossref","first-page":"6888","DOI":"10.1158\/1078-0432.CCR-17-1317","article-title":"Prospective validation of molecular prognostic markers in cutaneous melanoma: a correlative analysis of E1690","volume":"23","author":"Kashani-Sabet","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2020.12.015_bib30","doi-asserted-by":"crossref","first-page":"6987","DOI":"10.1158\/1078-0432.CCR-09-1777","article-title":"A\u00a0multimarker prognostic assay for primary cutaneous melanoma","volume":"15","author":"Kashani-Sabet","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2020.12.015_bib31","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1756-9966-29-127","article-title":"Reduction of lung metastasis, cell invasion, and adhesion in mouse melanoma by statin-induced blockade of the Rho\/Rho-associated coiled-coil-containing protein kinase pathway","volume":"29","author":"Kidera","year":"2010","journal-title":"J\u00a0Exp Clin Cancer Res"},{"key":"10.1016\/j.jid.2020.12.015_bib32","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1016\/j.ejca.2007.09.004","article-title":"Is statin use associated with a reduced incidence, a reduced Breslow thickness or delayed metastasis of melanoma of the skin?","volume":"43","author":"Koomen","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jid.2020.12.015_bib33","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nrc2044","article-title":"The Connectivity Map: a new tool for biomedical research","volume":"7","author":"Lamb","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jid.2020.12.015_bib34","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease","volume":"313","author":"Lamb","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.jid.2020.12.015_bib35","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1084\/jem.20180654","article-title":"IFN\u03b3-activated dermal lymphatic vessels inhibit cytotoxic T cells in melanoma and inflamed skin","volume":"215","author":"Lane","year":"2018","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jid.2020.12.015_bib36","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJMoa1910836","article-title":"Five-year survival with combined nivolumab and ipilimumab in advanced melanoma","volume":"381","author":"Larkin","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2020.12.015_bib37","doi-asserted-by":"crossref","first-page":"677.e1","DOI":"10.1016\/j.jaad.2009.03.016","article-title":"Selection criteria for genetic assessment of patients with familial melanoma","volume":"61","author":"Leachman","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2020.12.015_bib38","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/pcmr.12374","article-title":"Toward predicting metastatic progression of melanoma based on gene expression data","volume":"28","author":"Li","year":"2015","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jid.2020.12.015_bib39","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1158\/1940-6207.CAPR-13-0189","article-title":"A\u00a0randomized, double-blind, placebo-controlled phase II clinical trial of lovastatin for various endpoints of melanoma pathobiology","volume":"7","author":"Linden","year":"2014","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.jid.2020.12.015_bib40","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/cam4.285","article-title":"Statin use and its effect on all-cause mortality of melanoma patients: a population-based Dutch cohort study","volume":"3","author":"Livingstone","year":"2014","journal-title":"Cancer Med"},{"key":"10.1016\/j.jid.2020.12.015_bib41","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0188-0128(98)00018-9","article-title":"Security and maximal tolerated doses of fluvastatin in pediatric cancer patients","volume":"30","author":"L\u00f3pez-Aguilar","year":"1999","journal-title":"Arch Med Res"},{"key":"10.1016\/j.jid.2020.12.015_bib42","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.celrep.2012.01.005","article-title":"VEGF-C promotes immune tolerance in B16 melanomas and cross-presentation of tumor antigen by lymph node lymphatics","volume":"1","author":"Lund","year":"2012","journal-title":"Cell Rep"},{"key":"10.1016\/j.jid.2020.12.015_bib43","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1158\/2159-8290.CD-15-0023","article-title":"Lymphatic vessels, inflammation, and immunity in skin cancer","volume":"6","author":"Lund","year":"2016","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jid.2020.12.015_bib44","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1172\/JCI79434","article-title":"Lymphatic vessels regulate immune microenvironments in human and murine melanoma","volume":"126","author":"Lund","year":"2016","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2020.12.015_bib45","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1038\/s41467-019-09799-2","article-title":"Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen","volume":"10","author":"Menden","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2020.12.015_bib46","doi-asserted-by":"crossref","first-page":"6076","DOI":"10.18632\/oncotarget.3475","article-title":"HSET overexpression fuels tumor progression via centrosome clustering-independent mechanisms in breast cancer patients","volume":"6","author":"Pannu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jid.2020.12.015_bib47","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3389\/fimmu.2013.00062","article-title":"Statins reduce melanoma development and metastasis through MICA overexpression","volume":"4","author":"Pich","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2020.12.015_bib48","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1755-8794-1-13","article-title":"The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis","volume":"1","author":"Riker","year":"2008","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.jid.2020.12.015_bib49","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1056\/NEJMoa1904059","article-title":"Five-year outcomes with dabrafenib plus trametinib in metastatic melanoma","volume":"381","author":"Robert","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2020.12.015_bib50","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1056\/NEJM199908053410604","article-title":"Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group","volume":"341","author":"Rubins","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2020.12.015_bib51","doi-asserted-by":"crossref","first-page":"96ra77","DOI":"10.1126\/scitranslmed.3001318","article-title":"Discovery and preclinical validation of drug indications using compendia of public gene expression data","volume":"3","author":"Sirota","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jid.2020.12.015_bib52","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1055\/s-2003-40964","article-title":"The statins: multifunctional antithrombotic and antineoplastic drugs","volume":"29","author":"Splichal","year":"2003","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jid.2020.12.015_bib53","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41586-019-1847-2","article-title":"Metabolic heterogeneity confers differences in melanoma metastatic potential","volume":"577","author":"Tasdogan","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jid.2020.12.015_bib54","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/j.1552-4604.1992.tb05773.x","article-title":"Pharmacokinetics of fluvastatin after single and multiple doses in normal volunteers","volume":"32","author":"Tse","year":"1992","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.jid.2020.12.015_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ceb.2015.08.002","article-title":"The MAGE protein family and cancer","volume":"37","author":"Weon","year":"2015","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.jid.2020.12.015_bib56","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12935-019-1064-y","article-title":"Silencing of microRNA-517a induces oxidative stress injury in melanoma cells via inactivation of the JNK signaling pathway by upregulating CDKN1C","volume":"20","author":"Yang","year":"2020","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.jid.2020.12.015_bib57","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12885-018-4016-3","article-title":"Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients","volume":"18","author":"Zager","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jid.2020.12.015_bib58","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.3892\/ijo.2013.2126","article-title":"Simvastatin reduces melanoma progression in a murine model","volume":"43","author":"Zanfardino","year":"2013","journal-title":"Int J Oncol"},{"key":"10.1016\/j.jid.2020.12.015_bib59","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1586\/17469872.3.5.569","article-title":"Current concepts of metastasis in melanoma","volume":"3","author":"Zbytek","year":"2008","journal-title":"Expert Rev Dermatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X20324131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X20324131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T21:45:37Z","timestamp":1762206337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X20324131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0022202X20324131"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2020.12.015","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Computational Drug Repositioning Identifies Statins as Modifiers of Prognostic Genetic Expression Signatures and Metastatic Behavior in Melanoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2020.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}